Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I004 Biosimilar vs NovoLog PK/PD Study
NCT05539872Phase 3Completed
- Start
- Aug 2022
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in diabetes mellitus (DM). Started Aug 2022; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT05539872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05539872.